Sana Biotechnology, Inc. (SANA) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Price / Book | 7.26 |
| FCF Yield | -23.0% |
| Sector P/E (Healthcare) | 21.6 |
SANA overview · SANA earnings · SANA KPIs · SANA investor relations · SANA ownership · SANA peers · SANA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.